Floatz logo

NEPENTHE

Subarachnoid Hemorrhage

Dalhousie UniversitySmall moleculePhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Subarachnoid Hemorrhage cohort.

Asset / SponsorPhaseRating
PROPOFOL
Azienda Ospedaliera San Gerardo di Monza
Phase 4BB
ISOFLURANE
Azienda Ospedaliera San Gerardo di Monza
Phase 4BB
DICLOFENAC
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Phase 4BB
Rivaroxaban
University of Edinburgh
Phase 3BB
Edoxaban
University of Edinburgh
Phase 3BB

View all 24 →

Same molecule, other indications

NEPENTHE is also rated in:

PainDormant
BBB
Indicative ·
77 / 100
View asset →
cancer of unknown primary siteDormant
BBB
Indicative ·
75 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →